Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation
Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.
OpenFDA device adverse-event casebook.
FDA MAUDE casebook
openFDA event book Percutaneous Cardiac Ablation Catheter For… LIGHT-BOOK · MAUDE
#276 of 1000 · 6,348 reports · 2024–2026
- BOOK 6,348 reports
- RANK #276 of 1000
- DEATH 156 death-typed
- INJ 2,630 injury-typed
- MALF 3,559 malfunction
- SPAN 2024–2026
- PEAK 2025: 4,131
- PHOTO System
Nearest event-volume peer: System, Imaging, Pulsed Echo, Ultrasonic (13 report gap)
Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation sits #276 of 1000 among tracked device types with 6,348 MAUDE reports spanning 2024–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →
Event-type mix vs corpus
Shares of FDA event_type codes on this device type, compared with the mean across 1,000 device types that have ≥100 MAUDE reports. Codes are report labels, not adjudicated causation.
- DEATH 2.5% corpus 1.5% · above corpus mean (+0.9 pp)
- INJ 41.4% corpus 30.4% · above corpus mean (+11.0 pp)
- MALF 56.1% corpus 64.5% · below corpus mean (-8.4 pp)
Lead product-problem code Adverse Event Without Identified Device or Use Problem is 29% of coded problems · Lead manufacturer BOSTON SCIENTIFIC CORPORATION accounts for 61% of manufacturer-tagged reports · Top event location is 99% of location-tagged rows .
Percutaneous Cardiac Ablation Catheter For… in the event-volume neighbourhood
FDA MAUDE report totals among this device type and nearest nationwide peers
- Tube
Tube, Tracheostomy (W/Wo Connector)
6,484 reports
- Hearing Aid
Hearing Aid, Bone Conduction, Implanted
6,463 reports
- Percutaneous… (this)
Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation
6,348 reports
- System
System, Imaging, Pulsed Echo, Ultrasonic
6,335 reports
- Prosthesis
Prosthesis, Ankle, Semi-Constrained, Cemented, Metal/Polymer
6,304 reports
- Device
Device, Thermal Ablation, Endometrial
6,244 reports
What this shows Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation carries 6,348 MAUDE reports, ranked #276 of 1000.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Top Product Problems
Yearly Trend
Related Entities for Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation
Top Manufacturers
Event Locations
Compare BOSTON SCIENTIFIC CORPORATION vs MEDTRONIC CRYOCATH LP →
Nationwide devices with similar MAUDE profiles
Two openFDA-derived peer sets for Percutaneous Cardiac Ablation Catheter For…, both floored at ≥100 reports so the neighborhoods stay in the advertised mass.
Similar report volume
Nearest other device types by FDA MAUDE report count (6,348 here).
Similar death-typed counts
Nearest other device types by death-typed report count (156 here), distinct from the volume row.
Read our methodology - how this data is sourced, computed, and verified.
Disclaimer: MAUDE figures for Percutaneous Cardiac Ablation Catheter For… are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.
Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Percutaneous Cardiac Ablation Catheter For…; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.